In Vivo Self-Assembly Based Cancer Therapy Strategy

Area of Science:

• Biomedical Engineering
• Nanomedicine
• Oncology

Background:

• Nanotechnology is crucial for cancer imaging, diagnostics, and therapy.
• In vivo self-assembly offers an alternative to prefabricated nanomaterials for cancer treatment.
• Small molecules assemble into nanostructures within the body, potentially improving drug delivery.

Purpose of the Study:

• To review the progress and advantages of in vivo self-assembly for cancer therapy.
• To explore nanostructure self-assembly induced by specific tumor microenvironment stimuli.
• To highlight the utilization of these self-assembled nanostructures in cancer treatment.

Main Methods:

• Review of existing literature on in vivo self-assembly in cancer therapy.
• Analysis of stimuli-responsive self-assembly mechanisms (pH, ROS, enzymes, etc.).
• Evaluation of advantages like high drug capacity, reduced resistance, and enhanced retention.

Main Results:

• In vivo self-assembly demonstrates high selectivity for cancer cells due to tumor microenvironment specificity.
• Advantages include faster diffusion of small molecules compared to pre-formed nanostructures.
• Significant progress has been made in the last decade, showing promise for clinical application.

Conclusions:

• In vivo self-assembly is a promising strategy for advanced cancer therapy.
• Stimuli-responsive self-assembly offers targeted and efficient cancer treatment.
• This approach presents advantages over traditional nanomedicine strategies.